← Eichor
Study identifier: NCT05975203 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Continuous Delivery Room Skin-to-skin-study for Moderate and Late Preterm Infants

Condition: Preterm Birth · Mother-Infant Interaction · Infant Development  ·  Sponsor: University of Cologne

PhaseNA
Planned participants60
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

The goal of this randomized controlled trial is to compare the effect of direct skin-to-skin contact in moderate and late preterm infants. The main questions it aims to answer are: * does skin-to-skin contact in moderate and late preterm infants influence gene expression in the stress signaling pathway? * does skin-to-skin contact in moderate and late preterm infants improve the short- and long-term outcome? Participants will either get immediate separation after vaginal birth or receive immediate skin-to-skin contact. Researchers will compare these two groups to answer the proposed questions.

This description comes directly from the study's public registry record.

Talk to the study team

Katrin Mehler, PD Dr.  ·  004922147885663  ·  katrin.mehler@uk-koeln.de

Angela Kribs, PD Dr.  ·  004922147885663  ·  angela.kribs@uk-koeln.de

Always discuss trial participation with your own doctor first.

Locations (1)

University hospital of Cologne, Department of NeonatologyCologne, Northrhine-westfalia, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05975203